Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is there still a need for albumin infusions to treat patients with liver disease?

Literature DB >> 10764695

Is there still a need for albumin infusions to treat patients with liver disease?

P Ginès¹, V Arroyo.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2000 PMID： 10764695 PMCID： PMC1727922 DOI： 10.1136/gut.46.5.588

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

28 in total

1. OSMOTIC FACTORS INFLUENCING THE FORMATION OF ASCITES IN PATIENTS WITH CIRRHOSIS OF THE LIVER.

Authors: H Mankin; A Lowell
Journal: J Clin Invest Date: 1948-01 Impact factor: 14.808

2. Historical aspects of treatment of patients with cirrhosis and ascites.

Authors: B A Runyon
Journal: Semin Liver Dis Date: 1997 Impact factor: 6.115

3. Progress in liver disease: physiological factors involved in the causation of cirrhotic ascites.

Authors: M H Witte; C L Witte; A E Dumont
Journal: Gastroenterology Date: 1971-11 Impact factor: 22.682

Review 4. Peripheral arterial vasodilatation: determinant of functional spectrum of cirrhosis.

Authors: R W Schrier; M Niederberger; A Weigert; P Ginès
Journal: Semin Liver Dis Date: 1994-02 Impact factor: 6.115

5. Studies on the renin-angiotensin-aldosterone system in patients with cirrhosis and ascites: effect of saline and albumin infusion.

Authors: P Y Wong; R E Carroll; T L Lipinski; R R Capone
Journal: Gastroenterology Date: 1979-12 Impact factor: 22.682

6. Transvascular escape rate of albumin in liver cirrhosis, and its possible role in formation of ascites.

Authors: J H Henriksen; K Winkler
Journal: Scand J Gastroenterol Date: 1977 Impact factor: 2.423

7. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Authors: P Sort; M Navasa; V Arroyo; X Aldeguer; R Planas; L Ruiz-del-Arbol; L Castells; V Vargas; G Soriano; M Guevara; P Ginès; J Rodés
Journal: N Engl J Med Date: 1999-08-05 Impact factor: 91.245

8. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.

Authors: M Guevara; P Ginès; G Fernández-Esparrach; P Sort; J M Salmerón; W Jiménez; V Arroyo; J Rodés
Journal: Hepatology Date: 1998-01 Impact factor: 17.425

9. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.

Authors: P Angeli; R Volpin; D Piovan; A Bortoluzzi; R Craighero; S Bottaro; G F Finucci; E Casiglia; A Sticca; R De Toni; L Pavan; A Gatta
Journal: Hepatology Date: 1998-10 Impact factor: 17.425

10. Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor.

Authors: K Lenz; H Hörtnagl; W Druml; H Reither; R Schmid; B Schneeweiss; A Laggner; G Grimm; A L Gerbes
Journal: Gastroenterology Date: 1991-10 Impact factor: 22.682

7 in total

Review 1. The hepatorenal syndrome.

Authors: L Dagher; K Moore
Journal: Gut Date: 2001-11 Impact factor: 23.059

2. Ascites.

Authors: Nelson Garcia; Arun J. Sanyal
Journal: Curr Treat Options Gastroenterol Date: 2001-12

3. Changes in vitamin D binding protein and vitamin D concentrations associated with liver transplantation.

Authors: Peter P Reese; Roy D Bloom; Harold I Feldman; Ari Huverserian; Arwin Thomasson; Justine Shults; Takayuki Hamano; Simin Goral; Abraham Shaked; Kimberly Olthoff; Michael R Rickels; Melissa Bleicher; Mary B Leonard
Journal: Liver Int Date: 2011-09-09 Impact factor: 5.828

Review 7. Albumin for end-stage liver disease.

Authors: June Sung Lee
Journal: Korean J Intern Med Date: 2012-02-28 Impact factor: 2.884